Patricia C. Hirano - 31 Mar 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Vice President, Regulatory Affairs
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 16:05:47 UTC
Previous filing
01 Feb 2022
Next filing
29 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Purchase +20,000 +17% 139,104 31 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Warrant (right to buy) Purchase +20,000 20,000 31 Mar 2022 Common Stock 20,000 $0.3000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25.

Remarks:

Vice President, Regulatory Affairs